AI2 Incubator spinout Modulus sells cell therapy tech assets to Boston s Ginkgo Bioworks – GeekWire geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of.
Ginkgo Bioworks (DNA) Acquires Modulus Therapeutics Cell Therapy Assets streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PitchBook recently released a report on thermal battery companies, which is starting to produce some notable companies, and could be an area that garners more investment from VCs moving forward.